The phase 2/3 NRG GU002 trial (NCT03070886) evaluated whether adding 6 cycles of docetaxel after radiation and androgen ...
Patients with prostate cancer can receive radiation after prostatectomy in 25 treatments over 5 weeks instead of 37 treatments over 7 weeks. Long-term data from the NRG-GU003 tria ...
HT Health Talk: Prostate cancer is common but often silent. Should you get checked earlier if your father or brother had it?
Radiation therapy starts damaging cancer cells during treatment, but most cells do not die immediately. Radiation works ...
A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.
September 30, 2026, 10:01 to October 7, 2026, 10:01 (JST)This week, progress was made in preparing for U.S. regulatory ...
At 8 years, SBRT and radical prostatectomy had similar disease control in the PACE-A trial, with less urinary incontinence ...
Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.
So far, I have talked about the mechanism of TomoTherapy and how treatment plans are created.Now, how is treatment considered ...
Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...
Jacksonville Journal-Courier on MSN
Prostate cancer: Are you at risk, and should you get screened?
Prostate cancer screening generally begins around age 50, while men at higher risk may consider starting earlier, closer to ...
Veracyte, Inc. recently presented retrospective ancillary Phase III NRG/RTOG 0815 trial data at the 2026 ASTRO meeting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results